The Paradoxical Influence of Hyperthermia on Progression‐Free Survival in Recurrent/Metastatic Oral Cancer Treated With Immune Checkpoint Inhibitors
Oral Diseases · 2025
DOI: 10.1111/odi.70051 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2025. Verfasst von Shogo Kikuta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dental and Oral Medical Center, Kurume University School of Medicine, Fukuoka, Japan. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Mouth Neoplasms, Neoplasm Recurrence, Local, Hyperthermia, Induced. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Background
Clinical evidence for combining hyperthermia (HT) with immune checkpoint inhibitors (ICIs) in recurrent/metastatic oral cancer (RM‐OC) is lacking. To our knowledge, this is the first study to investigate the clinical impact of this combination therapy in this specific cohort.
Methods
We retrospectively analyzed 35 patients with RM‐OC treated with ICIs. Patients receiving concurrent HT ( n = 8) were compared to those without HT ( n = 27). Progression‐free survival (PFS) and overall survival (OS) were evaluated using Kaplan–Meier and Cox proportional hazards models.
Results
A significant discordance between endpoints emerged. Multivariate analysis revealed that concurrent HT was paradoxically associated with significantly worse PFS (hazard ratio, 3.06; 95% confidence interval, 1.08–8.64; p = 0.035). In stark contrast, HT had no corresponding negative impact on OS (median OS: 26.2 vs. 30.2 months; p = 0.53).
Conclusion
Concurrent HT with ICI therapy was paradoxically associated with diminished PFS without impacting OS. This critical discordance suggests that the observed radiographic progression may reflect intense, HT‐induced immune‐related inflammation (pseudoprogression) rather than true tumor progression. These findings underscore the complexity of interpreting efficacy endpoints for this novel combination therapy and highlight the need to reconsider standard response evaluation criteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dental and Oral Medical Center, Kurume University School of Medicine, Fukuoka, Japan.
- Department of Radiology, Kurume University School of Medicine, Kurume, Japan.
ORCID-Profile: Shogo Kikuta
Zitieren
APA
Kikuta, S., Hattori, C., Abe, Y., Hino, K., Matsuo, K., & Kusukawa, J. (2025). The Paradoxical Influence of Hyperthermia on Progression‐Free Survival in Recurrent/Metastatic Oral Cancer Treated With Immune Checkpoint Inhibitors. Oral Diseases. https://doi.org/10.1111/odi.70051
Vancouver
Kikuta S, Hattori C, Abe Y, Hino K, Matsuo K, Kusukawa J. The Paradoxical Influence of Hyperthermia on Progression‐Free Survival in Recurrent/Metastatic Oral Cancer Treated With Immune Checkpoint Inhibitors. Oral Diseases. 2025. doi:10.1111/odi.70051
BibTeX
@article{Kikuta2025,
author = {Kikuta, Shogo and Hattori, Chikayuki and Abe, Yushi and Hino, Kiyosato and Matsuo, Katsuhisa and Kusukawa, Jingo},
title = {The Paradoxical Influence of Hyperthermia on Progression‐Free Survival in Recurrent/Metastatic Oral Cancer Treated With Immune Checkpoint Inhibitors},
journal = {Oral Diseases},
year = {2025},
doi = {10.1111/odi.70051}
}
EUVIMED